Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 5/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | CHRM2 | P08172 | 1/20 | 0.32 |
| ▸ | CHRM4 | P08173 | 1/20 | 0.32 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.32 |
| ▸ | TBXA2R | P21731 | 1/20 | 0.32 |
| ▸ | GALR3 | O60755 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | BLM | P54132 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2149328 | 0.80 | TSHR (0.36) | TSHRALDH1A1TDP1CHRM2CHRM4 | |
| SCHEMBL6054113 | 0.80 | TSHR (0.36) | TSHRALDH1A1TDP1CHRM2CHRM4 | |
| SCHEMBL2846040 | 0.79 | TSHR (0.52) | TSHRALDH1A1TDP1 | |
| SCHEMBL475928 | 0.78 | TSHR (0.35) | TSHR | |
| SCHEMBL7924035 | 0.78 | TSHR (0.35) | TSHRALDH1A1TDP1CHRM2CHRM4 | |
| SCHEMBL476108 | 0.78 | TSHR (0.35) | TSHRALDH1A1TDP1CHRM2CHRM4 | |
| SCHEMBL1087173 | 0.78 | — | — | |
| SCHEMBL1087036 | 0.78 | — | — | |
| SCHEMBL1087267 | 0.78 | — | — | |
| SCHEMBL4641807 | 0.76 | TSHR (0.34) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 67 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8148446-B2 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | SIGMAKALON B.V. (NL) | 2012-04-03 | — | — | US | claimed |
| US-20100249298-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | GILLARD MICHEL | 2010-09-30 | — | — | US | claimed |
| US-20070161722-A1 | Silyl Esters, Their Use in Binder Systems and Paint Compositions and a Process for Production Thereof | SIGMA COATINGS B.V. (NL) | 2007-07-12 | — | — | US | claimed |
| EP-1620514-A2 | SILYL ESTERS, THEIR USE IN BINDER SYSTEMS AND PAINT COMPOSITIONS AND A PROCESS OF PRODUCTION THEREOF | SigmaKalon B.V. (NL) | 2006-02-01 | — | — | EP | claimed |
| EP-1606329-A1 | A PROCESS FOR THE PRODUCTION OF ACID GROUP CONTAINING POLYMER RESIN | SigmaKalon B.V. (NL) | 2005-12-21 | — | — | EP | claimed |
| EP-1606338-A1 | A PROCESS FOR THE PROTECTION OF ACID GROUPS IN POLYMERS | SigmaKalon B.V. (NL) | 2005-12-21 | — | — | EP | claimed |
| US-20050222446-A1 | Process for the production of hydrocarbyl silyl carboxylate compounds | SIGMA COATINGS B.V. (NL) | 2005-10-06 | — | — | US | claimed |
| EP-1572701-A1 | PROCESS FOR THE PRODUCTION OF HYDROCARBYL SILYL CARBOXYLATE COMPOUNDS | SIGMA COATINGS B.V. (NL) | 2005-09-14 | — | — | EP | claimed |
| WO-2004099326-A2 | SILYL ESTERS, THEIR USE IN BINDER SYSTEMS AND PAINT COMPOSITIONS AND A PROCESS OF PRODUCTION THEREOF | SIGMAKALON B.V. (NL) | 2004-11-18 | — | — | WO | claimed |
| EP-1475415-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | SigmaKalon Services B.V. (NL) | 2004-11-10 | — | — | EP | claimed |
| WO-2004085518-A1 | A PROCESS FOR THE PROTECTION OF ACID GROUPS IN POLYMERS | SIGMAKALON B.V. (NL) | 2004-10-07 | — | — | WO | claimed |
| WO-2004085502-A1 | A PROCESS FOR THE PRODUCTION OF ACID GROUP CONTAINING POLYMER RESIN | SIGMAKALON B.V. (NL) | 2004-10-07 | — | — | WO | claimed |
| EP-1462467-A1 | A process for the production of silyl group containing polymer resin | Sigma Kalon Services B.V. (NL) | 2004-09-29 | — | — | EP | claimed |
| EP-1462472-A1 | A process for the protection of acid groups in polymers | Sigma Kalon Services B.V. (NL) | 2004-09-29 | — | — | EP | claimed |
| WO-2004056837-A1 | PROCESS FOR THE PRODUCTION OF HYDROCARBYL SILYL CARBOXYLATE COMPOUNDS | SIGMA COATINGS B.V. (NL) | 2004-07-08 | — | — | WO | claimed |
| EP-2912120-B1 | ANTIFOULING COATING COMPOSITION | JOTUN AS (NO) | 2017-12-20 | — | — | EP | disclosed |
| EP-2935288-B1 | SILYL ESTER COPOLYMER | JOTUN AS (NO) | 2016-10-19 | — | — | EP | disclosed |
| EP-1172393-A1 | CURABLE RESIN COMPOSITION, PROCESS FOR PRODUCING THE SAME, AND COATED OBJECT MADE WITH THE SAME | DAICEL CHEMICAL INDUSTRIES, Ltd. (JP) | 2002-01-16 | — | — | EP | disclosed |
| US-6096836-A | OXYGEN CONTAINING AROMATIC CATALYST AND ALUMINUM COMPOUND | KABUSHIKI KAISHA TOSHIBA (JP) | 2000-08-01 | — | — | US | disclosed |
| US-5811497-A | STORAGE STABLE EPOXY RESINS ACTIVATE THE CURING WHEN APPLYING THE HEAT; FLEXIBILITY, DIELECTRIC, MECHANICAL STRENGTH | KABUSHIKI KAISHA TOSHIBA (JP) | 1998-09-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100249298-A1 | Silyl esters, their use in binder systems and paint compositions and a process of production thereof | LCT, PCMT1, TST | TSHR 4814/4885ALDH1A1 2426/4885TDP1 2300/4885 |
| US-20050222446-A1 | Process for the production of hydrocarbyl silyl carboxylate compounds | FTO, SUCLG2, ALKBH3 | TSHR 4796/4885ALDH1A1 212/4885TDP1 4360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.